| Authors: |
Catcott KC; a ImmunoGen, Inc. , Waltham , MA., McShea MA; a ImmunoGen, Inc. , Waltham , MA., Bialucha CU; b Novartis Institutes for Biomedical Research , Cambridge , MA., Miller KL; c Novartis Institutes for Biomedical Research , Emeryville , CA., Hicks SW; a ImmunoGen, Inc. , Waltham , MA., Saxena P; b Novartis Institutes for Biomedical Research , Cambridge , MA., Gesner TG; b Novartis Institutes for Biomedical Research , Cambridge , MA., Woldegiorgis M; c Novartis Institutes for Biomedical Research , Emeryville , CA., Lewis ME; a ImmunoGen, Inc. , Waltham , MA., Bai C; a ImmunoGen, Inc. , Waltham , MA., Fleming MS; a ImmunoGen, Inc. , Waltham , MA., Ettenberg SA; b Novartis Institutes for Biomedical Research , Cambridge , MA., Erickson HK; a ImmunoGen, Inc. , Waltham , MA., Yoder NC; a ImmunoGen, Inc. , Waltham , MA. |
